Laparoscopic Resection in Crohn's More Cost-Effective Than Infliximab

(MedPage Today) — More QALYs gained and 1-year health costs were $10,000 less in European study

Source link

Related posts

Clinical courses and complications of young adults with Autosomal Recessive Polycystic Kidney Disease (ARPKD)


Rivoceranib fails to significantly improve OS in advanced gastric cancer


Paediatric Parenteral Nutrition: Where are we now? What is best practice?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy